# Cancer Center Support Grant

> **NIH NIH P30** · UNIVERSITY OF MINNESOTA · 2024 · $4,078,247

## Abstract

Overall Summary
The Masonic Cancer Center (MCC) is an NCI-designated Comprehensive Cancer Center dedicated to cancer
research, education, and patient care for the citizens of Minnesota. Since the time of the first award in 1997,
there has been growth of the membership and research base. In our original application, there were 89
members; this has increased to 245 members from 49 departments and 11 colleges and schools of the
University of Minnesota. Since our last renewal, there has been growth in cancer-related direct funding from
$71.8M to $88.1M, a 23% increase.
The MCC is organized into 6 Programs that focus on specific scientific themes: Screening, Prevention, Etiology
and Cancer Survivorship; Carcinogenesis and Chemoprevention; Genetic Mechanisms; Cell Mechanisms;
Immunology; and Transplant and Cellular Therapy. These programs are supported by 10 Shared Resources.
The past funding period has seen increased emphasis on developing our translational pipeline. The resources
available to members for effective translation have been reorganized under the leadership of a single
Associate Director (AD) with oversight of both the fiscal resources and “idea generating” Translational Working
Groups. Close collaboration between the AD for Translational Research and our AD for Clinical Research has
led to the emergence of multiple new interventional trials from the science of MCC.
MCC is a successful matrix organization in a large public research university that engages its faculty to focus
on the problem of cancer. As such, MCC has engaged the community within our entire catchment area,
established a longitudinal training pathway for learners, and is developing a plan for enhancing diversity within
our workforce and patient population. Our current period of support has been characterized by growth in NCI-
funded research; stability in our leadership; enhanced engagement of our community; and creation of several
new cancer-focused initiatives including a statewide cancer clinical trials network, a global cancer prevention
institute, and a developmental therapeutics initiative.
Together, these activities fulfill our aims to 1) conduct high-impact population, basic, translational, and clinical
research focused on eliminating the burden of cancer, especially in underrepresented populations; 2) provide
the administrative and research structure at the University of Minnesota to engage our partners in the conduct
of cancer research; 3) build multi- and transdisciplinary teams to address complex cancer problems; 4)
educate the next generation of cancer researchers with special emphasis on enhancing diversity within the
workforce; and 5) engage local, state, national, and international partners in helping MCC solve the problem of
cancer.

## Key facts

- **NIH application ID:** 10768141
- **Project number:** 2P30CA077598-26
- **Recipient organization:** UNIVERSITY OF MINNESOTA
- **Principal Investigator:** Jeffrey S. Miller
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $4,078,247
- **Award type:** 2
- **Project period:** 1998-06-01 → 2029-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10768141

## Citation

> US National Institutes of Health, RePORTER application 10768141, Cancer Center Support Grant (2P30CA077598-26). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10768141. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*